Home/Neurolief/Ron Belson
RB

Ron Belson

Vice President, Research & Development

Neurolief

Therapeutic Areas

Neurolief Pipeline

DrugIndicationPhase
Relivion MGAcute and chronic migraineCommercial
Proliv™RxMajor depressive disorderPhase 2